Caroline  Apovian MD, FACP, FACN's portrait

Caroline Apovian MD, FACP, FACN

Professor of Medicine and Pediatrics
Section of Endocrinology, Diabetes, and Nutrition
Boston University School of Medicine
Boston, MA
Dr. Apovian is a member of the EndocrineWeb Editorial Board.

About Caroline Apovian MD, FACP, FACN

Caroline Apovian is Professor of Medicine and Pediatrics, in the Section of Endocrinology, Diabetes, and Nutrition at Boston University School of Medicine, USA. She is also Director of the Center for Nutrition and Weight Management at Boston Medical Center, USA. Dr. Apovian is a nationally and internationally recognized authority on nutrition and has been in the field of obesity and nutrition since 1990. Her current research interests are in: weight loss and its effects on endothelial cell function, adipose cell metabolism and inflammation, research in the bariatric surgery population, and novel pharmacotherapeutic antiobesity agents. She is also an expert in the technique for subcutaneous adipose tissue biopsies, and has been performing these biopsies on research subjects for over 10 years. She was on the expert panel for updating the 2013 AHA/ACC/TOS Clinical Guidelines for the Management of Overweight and Obesity in Adults.

Dr. Apovian was a recipient of the Physician Nutrition Specialist Award given by the American Society of Clinical Nutrition. This was for her work on developing and providing nutrition education, to medical students and physicians in training at Boston University School of Medicine. She has published over 200 articles, chapters, and reviews on the topics of: obesity, nutrition, and the relationship between adipose tissue and risk of developing cardiovascular disease. Dr. Apovian has recently published a new book entitled the “The Age-Defying Diet” and has also written the popular books for “The Overnight Diet” and “The ALLI Diet Plan”.

Dr. Apovian has been a member of The Obesity Society since 1992, and has served on the Clinical Committee as well as Secretary/Treasurer and the Executive Committee from 2005 to 2008.  She has been a faculty speaker and has presented papers at several of the Society's Annual Scientific Meeting and until recently she served as Associate Editor for the Society's journal, Obesity.

 

For more information, please visit Dr. Apovian at Caroline Apovian, MD on Facebook.

Publications

Peer Reviewed Publications
1. Stuart RK, Shikora SA, Akerman P, Lowell JA, Baxter JK, Apovian C.M., Champagne C, Jennings A, Keane-Ellison M, Bistrian BR. Incidence of arrhythmia with central venous catheter insertion and exchange. JPEN: J Parenter Enteral Nutr 1990;14(2):152-5.

2. Stuart RK, Apovian CM, Bell SJ, Blackburn GL.  Perioperative nutrition in cancer patients. Nutrition 1990;6(4 Suppl):4S-6S.

3. Stuart RK, Baxter JK, Shikora SA, Akerman P, Apovian CM, Champagne C, Jennings A, Bistrian BR. Reducing arrhythmias associated with central venous catheter insertion or exchange. Nutrition 1992;8(1):19-21.

4. Thomas P, Rogers J, Fish J, Apovian CM, Jensen GL. Total parenteral nutrition in a patient with severe diabetic diarrhea. Nutrition 1995;11(5):456-60.

5. Rogers JZ, Thomas P, Apovian CM, Jensen GL. Pulmonary embolus as a complication of a central venous catheter. Nutrition 1996;12(4):271-3.

6. Fish J, Sporay G, Beyer K, Jones J, Kihara T, Kennedy A, Apovian CM, Jensen GL. A prospective randomized study of glutamine-enriched parenteral compared with  enteral feeding in postoperative patients. Am J Clin Nutr 1997;65(4):977-83.

7. Apovian CM, Frey CM, Heydt D, Wood GC, Rogers JZ, Still C, Jensen GL.  Body mass index and physical function in older women. Obes Res 2002;10(8):740-7.

8. Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L. Overnight Dexamethasone Suppression Test: A Reliable Screen for Cushing's Syndrome in the Obese. Obes Res 2002;10(12):1217-21.

9. Gokce N, Vita JA, McDonnell M, Forse RA, Istfan N, Stoeckl M, Lipinska I, Keaney Jr JF, Apovian CM. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiology 2005;95:266-8.

10. Saltzman E, Anderson W, Apovian CM, Boulton H, Chamberlain A, Cullum-Dugan D, Cummings S, Hatchigian E, Hodges ., Keroack CR, Pettus M, Thomason P, Veglia L, Young LS. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005;13:234-43.

11. Anderson WA, Greene GW, Forse RA, Apovian CM, Istfan NW. Weight loss and health outcome differences between African Americans and Whites following gastric bypass surgery. Obesity 2007;15:1455-63.

12. Early JL, Apovian CM, Fernstrom MH, Greenway FA, Heber D, Kushner RF, Cwik KM, Walch JK, Hewkin AC, Blakesley V. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients. Obesity 2007;15:1464-72.

13. Guo W, Bigornia S, Leizerman I, Xie W, McDonnell M, Clemente K, Pirtskhalava T, Kirkland JL, Gokce N, Corkey BE, Sullivan LM, Apovian CM. New Scanning electron microscope method for determination of adipocyte size in humans and mice. Obesity 2007;15:1657-65.

14. Arkin JM, Alsdorf R, Bigornia S, Palmisano J, Beal R, Istfan N, Hess D, Apovian CM, Gokce N. Relation of cumulative weight burden to vascular endothelial dysfunction in obesity. Am J Cardio 2008;101:98-101. PMCID: PMC2199378.

15. Vitseva O, Tanriverdi K, Tchkonia T, Kirkland JL, McDonnell M, Apovian CM, Freedman JA, Gokce N. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue. Obesity 2008;16(5):932-7. PMCID: PMC3264059.

16. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M, McDonnell M, Hess D, Joseph L, Gokce N. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterio Thromb Vascr Bio 2008;28(9):1654-9. PMCID: PMC2728436.

17. Apovian CM, Mechanick JI. Can lesser-known causes of obesity help build a more predictive physiological model? Curr Opin Endo 2008;15(5):401-2.

18. Usdan LS, Khaodhiar L, Apovian CM. The endocrinopathies of anorexia nervosa. Endocr Pract 2008;14(8):1055-63. PMCID: PMC3278909.

19. Moore TJ, Alsabeeh N, Apovian CM, Murphy MC, Coffman GA, Cullum-Dugan D, Jenkins M, Cabral H. Weight, blood pressure, and dietary benefits after 12 months of a Web-based Nutrition Education Program (DASH for health): longitudinal observational study. J Med Internet Res 2008;10 (4):e52. PMCID: PMC2629362.

20. Apovian CM, Bigornia S, Cullum-Dugan D, Schoonmaker C, Radziejowska J, Phipps J, Gokce N, Istfan N, Meyers A, Lenders C. Milk-based nutritional supplements in conjunction with lifestyle intervention in overweight adolescents. ICAN: Infant, Child, & Adolescent Nutrition 2009;1:37-44. PMCID: PMC3278916.

21. Lenders CM, Wright JA, Apovian CM, Hess DT, Shukla RR, Adams WG, Lee K. Weight Loss Surgery Eligibility According to Various BMI Criteria Among Adolescents. Obesity (Silver Spring) 2009; 17;150-55.

22. Knapp PE, Clemente KM, Phipps JC, Speckman JL, Sternthal E, Freund KM, Ash AS, Apovian C. M. Self-monitoring of blood glucose with finger tip vs. alternate site sampling: effect on glycemic control in insulin-using patients with type 2 diabetes. Diab Tech Ther 2009; 11: 219-225. PMCID: PMC3196050.

23. Bays HE, Laferrere B, Dixon J, Aronne L, Gonzalez-Campoy JM, Apovian C. M., Wolfe BM. Adisopathy and bariatric surgery: Is "sick fat" a surgical disease? Int J Clin Pract. 2009;63(9):1285-1300. PMCID: PMC2779983.

24. Apovian CM, Cullum-Dugan D, Lin PH, Gilbert KM, Coffman G, Jenkins M, Bakun P, Tucker KL, Moore TJ. Validation of a web-based dietary questionnaire designed for the DASH diet: The DASH online questionnaire. Public Health Nutr 2010;13(5):615-22. PMCID: PMC2859196.

25. Bigornia SJ, Mott MM, Hess D, Apovian CM, Duess MA, Kluge MA, Fiscale A, Vita JA, Gokce N. Long-term successful weight loss improves vascular endothelial function in severely obese individuals. Obesity (Silver Spring) 2010;18(4):754-9. PMCID: PMC2857970.

26. Hamburg NM, Mott M, Bigornia SJ, Duess MA, Kluge M, Hess D, Apovian CM, Vita JA, Gokce N. Maladaptive arterial remodeling in severe obesity is reversed with weight loss. Vasc Med. 2010;15(3):215-22. PMCID: PMC3077113.

27. Ruberg FL, Chen Z, Bigornia S, Guo Z, Hallock K, Hua N, Jara H, LaValley M, Phinikaridou A, Qiao Y, Viereck J, Apovian CM, Hamilton JA. The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome. Obesity (Silver Spring) 2010;18(6):1116-21. PMCID: PMC3264050.

28. Istfan NW, Anderson WA, Apovian CM, Hess DT, Forse A. Preoperative weight gain might increase risk of gastric bypass surgery. Surg Obes Relat Dis. 2011;7(2):157-64.

29. Gauthier MS, O'Brien EL, Bigornia S, Mott M, Cacicedo JM, Xu XJ, Gokce N, Apovian C, Ruderman N. Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem Biophys Res Commun. 2011;404(1):382-7. PMCID: PMC3061625.

30. Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM, Nikolajczyk BS. Elevated pro-inflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in Type 2 Diabetes. J Immunol. 2011;186(2):1162-72. PMCID: PMC3089774.

31. Farb MG, Bigornia S, Mott M, Tanriverdi K, Morin KM, Freedman JE, Joseph L, Hess DT, Apovian CM, Vita A, Gokce N. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol. 2011;58:232-7. PMCID: PMC3132399.

32. Pramyothin P, Biancuzzo RM, Lu Z, Hess DT, Apovian CM, Holick MF. Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after Roux-en-Y Gastric Bypass. Obesity (Silver Spring). 2011;19(11):2228-34.

33. Powell AG, Apovian C. M., Aronne LJ. The combination of phentermine and topiramate is an effective adjunct to diet and lifestyle modification for weight loss and measures of comorbidity in overweight or obese adults with additional metabolic risk factors. Evid Based Med. 2012;17(1):14-5.

34. Guo W, Li Y, Liang W, Wong S, Apovian CM, Kirkland JL, Corkey BE. Beta-Mecaptoethanol Suppresses Inflammation and Induces Adipogenic Differentiation in 3T3-F442A Murine Preadipocytes. PLoS ONE. 2012;7(7): 1-9. PMCID: PMC3402440.

35. Gorman AE, Kaye EA, Apovian CM, Fung T, Garcia R, Nunn M. Overweight and obesity predict time to periodontal disease progression in men. J Clin Periodontol. 2012;39:107-14. PMCID: PMC3258330.

36. Farb MG, Bigornia S, Mott M, Apovian CM, Ganley-Leal L, Liang YM, Ercan B, Widlansky M, Fiscale A, Carmine B, Hess DT, Vita JA, Gokce N. Arteriolar function in visceral adipose tissue is impaired in human obesity. Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):467-73. PMCID: PMC3262114.

37. Bigornia SJ, Farb MG, Mott MM, Hess DT, Carmine B, Fiscale A, Joseph L, Apovian CM, Gokce N. Relation of depot-specific adipose inflammation to insulin resistance in human obesity. Nutr Diabetes 2012 Mar 5;2:e30. PMCID: PMC3341707.

38. Xu XJ, Gauthier MS, Hess DT, Apovian CM, Cacicedo JM, Gokce N, Farb M, Valentine RJ, Ruderman NB. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res. 2012;53(4):792-801. PMCID: PMC3307656.

39. McDonnell ME, Ganley-Leal LM, Mehta A, Bigornia S, Mott M, Rehman Q, Farb MG, Hess D, Joseph L, Gokce N, Apovian CM. B lymphocytes in human subcutaneous adipose crown-like structures. Obesity (Silver Spring). 2012;20(7):1372-8. PMCID: PMC3682646.

40. Wee CC, Hamel MB, Apovian CM, Blackburn GL, Bolcic-Jankovic D, Colten ME, Hess DT, Huskey KW, Marcantonio ER, Schneider BE, Jones DB. Expectations for weight loss and willingness to accept risk among patients seeking weight loss surgery. JAMA Surg. 2013 Mar;148(3):264-71. PMC Journal - In Process.

41. Pramyothin P, Kim DW, Young LS, Wichansawakun S, Apovian CM. Anemia and Leukopenia in a Long-Term Parenteral Nutrition Patient During a Shortage of Parenteral Trace Element Products in the United States. JPEN J Parenter Enteral Nutr. 2013 May-Jun;37(3):425-9.

42. Ruth M, Wellman T, Mercier G, Szabo T, Apovian CM. An automated algorithm to identify and quantify brown adipose tissue in human (18) F-FDG-PET/CT scans. Obesity (Silver Spring). 2013 Aug;21(8):1554-60. PMCID: PMC3910095.

43. DeFuria J, Belkinab AC, Jagannathan-Bogdan M, Snyder-Cappionea J, Carr JD, Nersesova Y, Markhama D, Strissele KJ, Watkins A, Zhua M, Allen J, Bouchard J, Toraldo G, Jasuja R, Obin MS, McDonnell ME, Apovian C, Denis GV, Nikolajczyk BS. B cells promote inflammation in obesity and type 2 diabetes through regulation of T cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013 Mar;110(13):5133-8. PMCID: PMC3612635.

44. Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E; for the COR-II Study Group; Members listed at end of report. A randomized, phase 3 Trial of naltrexone SR/Bupropion SR on weight and obesity-related risk factors(COR-II). Obesity (Silver Spring). 2013 May;21(5):935-43. PMCID: PMC3739931.

45. Apovian CM. The clinical and economic consequences of obesity. Am J Manag Care. 2013 Aug;19(11 Sup):S219-28.

46. Westcott WL, Apovian CM, Puhala K, Corina L, Larosa Loud R, Whitehead S, Blum K, DiNubile N. Nutrition programs enhance exercise effects on body composition and resting blood pressure. Phys Sportsmed. 2013 Sep;41(3):85-91.

47. Ruth MR, Port AM, Shah M, Bourland AC, Istfan NW, Nelson KP, Gokce N, Apovian CM. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metabolism. 2013;62(12):1779-87. PMCID: PMC3845365.

48. Apovian CM, Huskey KW, Chiodi S, Hess DT, Schneider BE, Blackburn GL, Jones DB, Wee CC. Patient factors associated with undergoing laparoscopic adjustable gastric banding vs Roux-en-Y gastric bypass for weight loss. J Am Coll Surg. 2013 Dec;217(6):1118-25. PMC Journal - In Process.

49. Bigornia SJ, Farb MG, Tiwari S, Karki S, Hamburg NM, Vita JA, Hess DT, Lavalley MP, Apovian CM, Gokce N. Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol. 2013 Dec 17;62(24):2297-305. PMCID: PMC3873767.

50. Huong PT, Lam NT, Thu NN, Quyen TC, Lien DT, Anh NQ, Henry EG, Oliver L, Apovian CM, Ziegler TR, Lenders C. Prevalence of malnutrition in patients admitted to a major urban tertiary care hospital in Hanoi, Vietnam. Asia Pac J Clin Nutr. 2014;23(3):437-44.

51. Farb MG, Tiwari S, Karki S, Ngo DT, Carmine B, Hess DT, Zuriaga MA, Walsh K, Fetterman JL, Hamburg NM, Vita JA, Apovian CM, Gokce N. Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity (Silver Spring). 2014 Feb;22(2):349-55. PMCID: PMC3766380.

52. Wee CC, Mukamal KJ, Huskey KW, Davis RB, Colten ME, Bolcic-Jankovic D, Apovian CM, Jones DB, Blackburn GL. High-risk alcohol use after weight loss surgery. Surg Obes Relat Dis. 2014 May-Jun;10(3):508-13.

53. Hua N, Chen Z, Phinikaridou A, Pham T, Qiao Y, LaValley MP, Bigornia SJ, Ruth MR, Apovian CM, Ruberg FL, Hamilton JA. The influence of pericardial fat upon left ventricular function in obese females: evidence of a site-specific effect. J Cardiovasc Magn Reson. 2014 May 23;16(1):37. PMCID: PMC4046092.

54. Dhurandhar EJ, Dawson J, Alcorn A, Larsen LH, Thomas E, Cardel M, Bourland AC, Astrup A, St-Onge M, Hill JO, Apovian CM, Shikany J, Allison DB. The Effectiveness of Breakfast Recommendations on Weight Loss: A Randomized Controlled Trial. Am J Clin Nutr. 2014 Jun 4;100(2):507-513.

55. Ayalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, Donohue C, Perez AJ, Downing J, Gokce N, Miller EJ, Liang CS, Apovian CM, Colucci WS, Ho JE. Preclinical Left Ventricular Diastolic Dysfunction in Metabolic Syndrome. Am J Cardiol. 2014 Sep 15;114(6):838-42. PMCID: PMC4162746.

56. Boonchaya-Anant P, Holick MF, Apovian CM. Serum 25-hydroxyvitamin D levels and metabolic health status in extremely obese individuals. Obesity (Silver Spring). 2014 Dec;22(12):2539-43.

57. Stanford FC, Kyle TK, Claridy MD, Nadglowski JF, Apovian C.M. Bariatric Surgery and the influence of an individual's weight perception on its acceptance in the US. Obesity (Silver Spring). Obesity (Silver Spring). 2015 Feb;23(2):277-81.

58. Hasson BR, Apovian CM, Istfan N. Racial/Ethnic Differences in Insulin Resistance and Beta Cell Function: Relationship to Racial Disparities in Type 2 Diabetes among African Americans versus Caucasians. Curr Obes Rep. 2015 Jun;4(2):241-9.

59. Shikora SA, Wolfe BM, Apovian CM, Anvari M, Sarwer DB, Gibbons RD, Ikramuddin S, Miller CJ, Knudson MB, Tweden KS, Sarr MG, Billington CJ. Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial. J Obes. 2015 Jul 12. [Epub ahead of print] PMCID: PMC4515300.

60. Stanford FC, Jones DB, Schneider BE, Blackburn GL, Apovian CM, Hess DT, Chiodi S, Robert S, Bourland AC, Wee CC. Patient race and the likelihood of undergoing bariatric surgery among patients seeking surgery. Surg Endosc. 2015 Sep;29(9):2794-9.

61. Xu XJ, Apovian CM, Hess D, Carmine B, Ruderman N. Improved insulin sensitivity 3 months after RYGB surgery is associated with increased subcutaneous adipose tissue AMPK activity and decreased oxidative stress. Diabetes. 2015 Sep;64(9):3155-9.

62. Young LS, Huong PTT, Lam NT, Thu NN, Van HT, Hanh NL, Tuyen LD, Lien DTK, Hoc TH, Tuyet CT, Anh NQ, Henry EG, Lenders CM, Gura KM, Bigornia SA, Apovian C.M, Ziegler TR. Nutritional status and feeding practices in gastrointestinal surgery patients at Bach Mai Hospital, Hanoi, Vietnam. Asia Pac J Clin Nutr. 2015 (Accepted for publication)

Proceedings of Meetings and Invited Papers
1. Mechanick JI, Kushner RF, Sugerman HJ, Gozalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists. Obesity Society. American Society for Metabolic & Bariatric Surgery. Executive summary of the recommendations of the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 2008;14(3):318-36.

2. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endo Pract 2008;14 Suppl 1:1-83.

3. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008;4(5 Suppl):S109-84.

4. Blackburn GL, Hutter MM, Harvey AM, Apovian CM, Boulton HR, Cummings S, Fallon JA, Greenberg I, Jiser ME, Jones DB, Jones SB, Kaplan LM, Kelly JJ, Kruger RS Jr, Lautz DB, Lenders CM, Lonigro R, Luce H, McNamara A, Mulligan AT, Paasche-Orlow MK, Perna FM, Pratt JS, Riley SM Jr, Robinson MK, Romanelli JR, Saltzman E, Schumann R, Shikora SA, Snow RL, Sogg S, Sullivan MA, Tarnoff M, Thompson CC, Wee CC, Ridley N, Auerbach J, Hu FB, Kirle L, Buckley RB, Annas CL.Expert panel on weight loss surgery report – executive report update. Obesity (Silver Spring) 2009;17: 842-62.

5. Apovian CM, Cummings S, Anderson W, Borud L, Boyer K, Day K, Hatchigian E, Hodges B, Patti ME, Pettus M, Perna F, Rooks D, Saltzman E, Skoropowski J, Tantillo M, Thomason P. Best practice updates for multidisciplinary care in weight loss surgery. Obesity 2009; 17:871-9. PMCID: PMC2859198.

6. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Spitz AF, Apovian CM, Livingston EH, Brolin R, Sarwer DB, Anderson WA, Dixon J, Guven S. American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring) 2009;17 Suppl 1:S1-70.

7. Apovian CM, Cummings S, Anderson W, Borud L, Boyer K, Day K, Hatchigian E, Hodges B, Patti ME, Pettus M, Perna F, Rooks D, Saltzman E, Skoropowski J, Tantillo MB, Thomason P. Best practice updates for multidisciplinary care in weight loss surgery. Obesity (Silver Spring) 2009;17(5):871-9.

8. Blackburn GL, Hutter MM, Harvey AM, Apovian CM, Boulton HR, Cummings S, Fallon JA, Greenberg I, Jiser ME, Jones DB, Jones SB, Kaplan LM, Kelly JJ, Kruger RS Jr, Lautz DB, Lenders CM, Lonigro R, Luce H, McNamara A, Mulligan AT, Paasche-Orlow MK, Perna FM, Pratt JS, Riley SM Jr, Robinson MK, Romanelli JR, Saltzman E, Schumann R, Shikora SA, Snow RL, Sogg S, Sullivan MA, Tarnoff M, Thompson CC, Wee CC, Ridley N, Auerbach J, Hu FB, Kirle L, Buckley RB, Annas CL. Expert panel on weight loss surgery: executive report update. Obesity (Silver Spring) 2009;17(5):842-62.

9. Apovian CM. Obesity medicine: a new subspecialty; Obesity and diabetes. Audio-Digest Internal Medicine 2013;60(8).

10. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38.

11. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Obesity (Silver Spring). 2014 Jul;22 Suppl 2:S5-S39.

12. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2985-3023.

13. Apovian CM, Mayurasakorn K. The Effect of Bariatric Surgery on Long-Term Type 2 Diabetes Remission and Vascular Complications. http://cardiometabolic.cardiosource.org/. October 20, 2014.

14. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015 Feb;100(2):342-362.

15. Apovian CM, Garvey TW, Ryan D. Challenging Obesity: Patient, Provider, and Expert Perspectives on the Roles of Available and Emerging Nonsurgical Therapies. Obesity 2015 Jul 23 Suppl 2:S1-S26.

16. Lotfi K, Palmer K, Apovian CM. Case Study: Weight Loss in a Patient with Type 2 Diabetes – the Challenge of Diabetes Management. Obesity 2015 Apr 23 Suppl 1 S11-2.

17. Apovian CM. The low-fat, low-carb debate and the theory of relativity. Am J Clin Nutr. 2015 Sep 2. [Epub ahead of print]
 

Editorials and Critical Reviews
1. Baden LA, Apovian CM, Imber MJ, Dover JS.  Vancomycin and induced linear IgA Bullous dermatosis [letter]. Arch Dermatol 1988;124(8):1186-8.

2. Apovian CM, McMahon M, Bistrian BR. Guidelines for refeeding the marasmic patient. Crit Care Med 1990;18(9):1030-3.

3. Still CD, Apovian CM, Jensen GL. Update on obesity treatment. The Gastroenterologist 1996;4:S107-S118.

4. Apovian CM, Frey CM, Rogers JZ, McDermott B, Jensen GL. Body mass index and physical function in obese older women [letter]. J Am Geriatr Soc 1996;44(12):1487-8.

5. Still CD, Apovian CM, Jensen GL. Failure to thrive in older adults [letter]. Ann Intern Med 1997;126(8):668-9.

6. Apovian CM. Antiobesity drugs: should they be used in the treatment of obesity? Nutr Clin Pract 1998;13(5):251-6.

7. Apovian CM. The use of pharmacologic agents in the treatment of the obese patient. J Am Osteopath Assoc 1999;99(10 Su Pt 2):S2-S7.

8. Apovian CM. The medical management of obesity and the role of pharmacotherapy: an update. Nutr Clin Pract 2000;15(1):5-12.

9. Apovian CM. Nutrition and Aging. Curr Opin Endocrinol Diab 2000;7:231-5.

10. Apovian CM. Nutritional assessment in the elderly: facing up to the challenges of developing new tools for clinical assessment. Nutrition 2001;17(1):62-3.

11. Kearns LR, Phillips MC, Ness-Abramof R, Apovian CM. Update on parenteral amino acids. Nutr Clin Pract 2001;16:219-25.

12. Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol 2002;34(3):207-20.

13. Ness-Abramof R, Apovian CM. An Update on Medical Therapy for Obesity. Invited Review Nutr Clin Pract 2003;18(4):145-55.

14. Apovian CM, Kushner R. Does obesity have to be a hormonal disorder for the endocrinologist to take notice? Curr Opin Endocrinol 2004;11:183-5.

15. Ness-Abramof R, Nabriski D, Apovian CM. Medical therapy for obesity: present and future. IMAJ 2004;6:760-5.

16. Apovian CM. Sugar-sweetened soft drinks, obesity, and type 2 diabetes. J Am Med Assoc 2004;292(8):1-2.

17. Panzer C, Apovian CM. Aggressive diets and lipid responses. Curr Cardio Rep 2004;6(6):464-473.

18. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 2005;82:923-34.

19. Ness-Abramof R, Apovian CM. Drug-induced weight gain. Timely Top Med Cardiovasc Dis 2005;9:E39.

20. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Obes Res 2005;13(11):1949-63.

21. Apovian CM, Baker C, Ludwig D, Hoppin A., Hsu G, Lenders C, Pratt JSS, Forse RA, Obrien A, Tarnoff M. Best practice guidelines in pediatric/adolescent weight loss surgery. Obes Res 2005;13:274-82.

22. Ness-Abramof R, Apovian CM. Drug-induced weight gain. Drugs of Today 2005;41:547-55.

23. Ness-Abramof R, Apovian CM. Diet modification for treatment and prevention of obesity. Endocrine 2006;29:5-9.

24. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. American Diabetes Association Writing Panel. Nutrition recommendations and interventions for diabetes – 2006: A position statement of the American Diabetes Association. Diab Care 2006;29:2140-2157.

25. Khaodhiar L, Apovian CM. Current perspectives of obesity and its treatment. Managed Care Interface 2007;20:24-31.

26. Pietras SM, Apovian CM. Preoperative and postoperative management of the bariatric surgical patient. J Clin Outcomes Manag 2007;14:262-74.

27. Wylie-Rosett J, Albright AA, Apovian C, Clark NG, Delahanty L, Franz MJ, Hoogwerf B, Kulkarni, Lichtenstein AH, Mayers-Davis E, Mooradian AD, Wheeler M. 2006-2007 American Diabetes Association Nutrition Recommendations: Issues for practice translation. J Am Dietetic Assoc 2007;107:1296-304.

28. Crosby SS, Apovian CM, Grodin MA. Hunger strikes, force feeding, and physicians' responsibilities. J Am Med Assoc 2007;298:563-6.

29. American Diabetes Association. Bantle JP, Wylie-Rosett J, Albright A., Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayers-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diab Care 2008;31(Suppl 1):S61-78.

30. Cummings S, Apovian CM, Khaodhiar L. Obesity surgery: evidence for diabetes prevention/management. J Am Dietetic Assoc 2008;108:S40-S44.

31. Berghofer A, Pischon T, Reinhold T, Apovian C., Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008;8:200.

32. Ness-Abramof R, Apovian CM. Waist circumference measurement in clinical practice. Nutr Clin Pract 2008;23(4):397-404.
 
33. Khaodhiar L, Cummings S, Apovian CM. Treating Diabetes and Pre-diabetes by Focusing on Obesity Management. Curr Diab Rep 2009;9(5):348-54. PMCID: PMC2857968.

34. Mechanick JI, Apovian C. M. Stressing over obesity. Curr Opin Endocrinol Diabetes Obes 2009;16(5):339.

35. Ness-Abramof R, Apovian CM. Future of obesity prevention and treatment. Stud Health Technol Inform. 2009; 149:386-95.

36. Apovian CM. Overweight in older children and adolescents: treatment or prevention? Arch Dis Child 2010;95:1-2. PMCID: PMC2857966.

37. Apovian CM. (Guest Editor) The causes, prevalence and treatment of obesity revisited in 2009: what have we learned so far? Am J Clin Nutr 2010;91(1):277S-279S.

38. Port AM, Apovian C. Metabolic support of the obese intensive care unit patient: a current perspective. Curr Opin Clin Nutr Metab Care 2010;13(2):184-91. PMCID: PMC3278904.

39. Apovian CM, Mechanick JI. Disrupting the food-fat connection. Curr Opin Endocrinol Diabetes Obes 2010;17:440.

40. Apovian CM, Shah MS, Ruth MR, August D, Kushner R, McMahon MM, Algers S. Board certification and credentialing in nutrition. JPEN J Parenter Enteral Nutr. 2010;34(6 Suppl):78S-85S.

41. McClave SA, Mechanick JI, Kushner RF, DeLegge MH, Apovian CM, Brill JV, Friedman G, Heimburger DC, Jaksic T, Martindale RG, Moore FA, Shikora SA. Compilation of recommendations from summit on increasing physician nutrition experts. JPEN J Parenter Enteral Nutr. 2010;34(6 Suppl):123S-32S.

42. Powell AG, Apovian CM, Aronne LJ. New drug targets for the treatment of obesity. Clin Pharmacol Ther. 2011;90(1):40-51.

43. Aronne LJ, Powell AG, Apovian CM. Emerging pharmacotherapy for obesity. Expert Opin Emerg Drugs. 2011;16(3):587-96.

44. Powell AG, Apovian CM, Aronne LJ. New drug targets for the treatment of obesity. Clin Pharmacol Ther. 2011;90(1):40-51.

45. Apovian CM. Management of diabetes across the course of disease: minimizing obesity-associated complications. Diabetes Metab Syndr Obes. 2011;4:353-69. PMCID: PMC3224657.

46. Igel LI, Aronne LJ, Powell AG, Apovian CM. advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus. Curr Atheroscler Rep. 2012;14(1):60-9.

47. Apovian CM, Gokce N. Obesity and cardiovascular disease. Circulation. 2012;125(9):1178-82. PMCID: PMC3693443.

48. Apovian CM, Korner J. Proven weight loss methods. J Clin Endocrinol Metab. 2012;97(7):A33-4.

49. Mechanick JI, Marchetti AE, Apovian CM, Benchimol AK, Bisschop PH, Bolio-Galvis A, Hegazi RA, Jenkins D, Mendoza E, Sanz ML, Sheu WH, Tatti P, Tsang MW, Hamdy O. Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep. 2012 Apr;12(2):180-94. PMCID: PMC3303078.

50. Apovian CM. Obesity medicine: a new specialty in medicine or a focus in endocrinology? Nutrition is the real subspecialty in medicine. Endocr Pract. 2012 Sep-Oct;18(5):649-50.

51. Mechanick JI, Apovian CM. Rethinking our approach to the obese patient: time to create the obesity treatment score. Current opinion in endocrinology, diabetes, and obesity." Curr Opin Endocrinol Diabetes Obes. 2012;19(5):339-40.

52. Magnani JW, Hylek EM, Apovian CM. Obesity begets atrial fibrillation: a contemporary summary. Circulation. 2013 Jul 23;128(4):401-5. PMCID: PMC3866045.

53. Apovian CM, Aronne LJ. Zonisamide for weight reduction in obese adults. JAMA. 2013 Aug 14;310(6):637-8.

54. Apovian CM, Mechanick JI. Obesity IS a disease! Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):367-8.

55. Apovian CM, Aronne LJ. Weight loss treatment in obese adults--reply. JAMA. 2013 Dec 18;310(23):2568.

56. Pi-Sunyer X, Jensen M, Ryan D, Apovian C.M, Millen B, Nonas C. We stand by our guidelines. Nat Rev Endocrinol. 2014 May;10(5):310.

57. Boonchaya-Anant P, Apovian CM. Metabolically Healthy Obesity-Does it Exist? Curr Atheroscler Rep. 2014 Oct;16(10):441.
 

Textbook Chapters
1. Blackburn GL, Apovian CM, Bothe A. "Nutritional factors in cancer." In: Calabresi P, ed. Medical Oncology. 2nd Ed. McGraw-Hill. New York, NY, 1993.

2. Apovian CM, Jensen G. Overnutrition and obesity management. In: Kirby D., ed. Modern Nutrition. CRC Press, Inc. Boca Raton, FL, 1994.

3. Still C, Apovian CM, Jensen GL. Malnutrition and related complications. In: Shiroka S. A., Blackburn G. L., eds. Nutrition Support: Theory and Therapeutics. Chapman & Hall. New York, NY, 1997.

4. Apovian CM, Still CD, Blackburn GL. Nutritional Support. In: Berger A., Portenoy R. K., Weissman D. E., eds. Principles and Practice of Supportive Oncology. Lipincott-Raven. Philadelphia, PA, 1998.

5. Koutkia P, Apovian CM, Blackburn GL. Nutrition Support. In Berger A, Portenoy RK, Weissman D, eds. Principles and Practice of Palliative Care and Supportive Oncology Second edition. Lipinscott Williams and Wilkins. Philadelphia, PA, 2002.

6. Abramof-Ness R, Apovian CM. Management of obesity in clinical practice. In: Sciarra J, ed. Gynecology and Obstetrics. Lippincott Williams & Wilkins Co. Chicago, IL, 2002.

7. Koutkia P, Apovian CM. Nutrition Support in the Critically Ill Diabetic Patient. In: Shikora SA, Martindale R. eds. Nutritional Considerations in the Intensive Care Unit. A.S.P.E.N., Kendall/Hunt Publishers, Dubuque, Iowa, 2002.

8. Apovian CM, Buranapin S. Obesity, method of In: Rackel RA, Bope ET. eds. Conn's Current Therapy 2004. Thomas H. Moore, Philadelphia, PA, 2004.

9. Buranapin S, Apovian CM. Antiobesity Agents and Cardiovascular Disease. In: Robinson MK, Thomas A, eds. Obesity and Cardiovascular Disease. New York, NY, 2004.

10. McDonnell M, Apovian CM. Other risk interventions: Obesity. In: Wenger N, ed. Women and Heart Disease, 2nd Edition. Martin Dunitez, London, 2005.

11. McDonnell M, Hess D, Apovian CM. Medical management of the patient after gastric bypass surgery. In: Forse RA, Farraye FF, eds. Bariatric Surgery – A Primer. Slack Inc, Thorafare, NJ, 2006.

12. Apovian C M. Gastric bypass surgery in the pediatric and elderly patient. In: Forse RA, Farraye FF, eds. Bariatric Surgery – A Primer. SLACK Inc, Thorofare, NJ, 2006.

13. Young L, Apovian CM. Nutrition in the Elderly. In: Bronner F. ed. Nutritional and Clinical Applications in Chronic Disorders and Diseases. CRC Press (Taylor and Francis), New Providence, PA, 2006.

14. Apovian C. Web-based education. In: Jones SB, Jones DB, eds. Obesity Surgery – Patient Safety and Best Practices. Cine-Med, Inc., Woodbury, CT, 2009.
 

Abstracts
1. Baxter J, Babineau T, Apovian C, Bistrain B, et al. Perioperative glucose predicts increased nosocomial infection in diabetics. Crit Care Med 1990;81:S207.

2. Apovian C, Jensen G, Sporay G. An investigation of dietary practice and functional status among rural elderly women with obesity. Int J Obest 1994;18(2 Suppl):30.

3. Dove M, Fish J, Apovian ., Jensen G. Cost-effective utilization of a nutrition support team decreases inappropriate laboratory monitoring of the TPN patient. Proceedings of A.S.P.E.N. 19th Clinical Congress, Miami, FL, January 1995.

4. Fish J, Sporay G, Jones J, Kihara T, Kennedy ., Apovian C, Beyer K, Jensen GL. A prospective randomized study of glutamine-enriched total parenteral versus enteral feeding in postoperative patients. Am J Clin Nutr 1996;61:897.

5. Booke B, Fish J, Apovian C, Jensen GL. Adjusting TPN for administration of amphotericin B with lipids. A.S.P.E.N. S400, 1996.

6. Jensen G, Apovian C, Kita K, Fish J. Obesity in older persons: a crisis in rural America. FASEB 1996;J 10.

7. Jensen GL, Apovian C, Kita K, Fish J. A managed care model for a regional approach to nutrition screening among rural older persons. J Am Geriatr Soc 1996;44:S32.

8. Apovian CM, Frey CM, Heydt ., Still C, Jensen GL. Body mass index (BMI) and physical function in older women. Obes Res 1997;5:2S.

9. Apovian C, Aronne L, Early J, Fernstrom M, Frank A, Greenway F, Heber D, Kushner R. The effect of combination therapy of sibutramine and meal replacement (Slim Fast ®) on body weight and weight loss maintenance in obese individuals. Obes Res 2001;9(SUPPL 3):68S.

10. Sarna PK, Moonesinghe KD, Cullum-Dugan D, Sternthal E, Apovian CM. Effects of metformin, sulfonylureas, and insulin on weight changes in patients with type II diabetes mellitus – a pilot study. Obes Res 2001;9(13 Suppl):585.

11. Young LS, Buranapin S, Curtis A, Apovian CM, Burke P. A New Nasojejunal Tube Placement Program by the Nutrition Support Service (NSS) in a Major Teaching Hospital Proves Cost Effective. NCP 2003;18(2).

12. Buranapin S, Abramof-Ness S, Apovian CM. Cardiovascular Risk Factors in Obese Women: Does Race Matter? Obes Res 2003;11(Suppl):A120.

13. Buranapin S, Abramof-Ness R, Apovian CM. Racial Disparities in Homocysteine, B12 and Folate in Obese Women. Obes Res 2003;11(Suppl):A64.

14. Abramof-Ness R, Buranapin S, Apovian CM. Obese African American women are less likely to be diagnosed with the metabolic syndrome compared to obese Caucasian and Hispanic women. Obes Res 2004;12(Suppl):A215.

15. Buranapin S, Bigornia S, Phipps J, Cullum-Dugan D, Apovian CM, et al. Do liquid meals replacements in addition to lifestyle changes affect adiposity indicators among adolescents at risk of overweight: A preliminary analysis. Obes Res 2004;12(Supp):A69.

16. Buranapin S, McDonnell ME, Apovian CM. Differences in successful weight loss among ethnic groups in an urban weight management program. Obes Res 2004;12(Suppl):A56.

17. Gokce N, Apovian CM. Effect of Medical and Surgical Weight Loss on Endothelial Cell Function in Obese Patients. American Heart Association Scientific Sessions, New Orleans, November 2004.

18. Fernstrom M, Kushner R, Apovian C, Hewkin A, Frevert E. The effect of combination therapy of sibutramine and meal replacement on body weight and weight-loss maintenance. 4th European Congress on Obesity, Athens, June 2005.

19. Gokce N, Vitseva O, Tanriverdi K, Alsdorf R, Guo W, Xie W, McDonnell M, Bigornia S, Clemente K, Apovian C, Freedman J. Toll-like receptor (TLR) expression in human adipose tissue. Obes Res 2005;13(Suppl):A22.

20. Guo W, Bigornia S, Xie K, McDonnell M, Clemente K, Leizerman I, Pirtskhalava T, Kirkland J, Corkey B, Gokce N, Behar V, Apovian C. A new method for determination of adipocyte size: correlations with weight loss and fat depot origin. Obes Res 2005;13(Suppl):A176.

21. Guo W, Corkey C, Apovian CM, Wong S. Fatty acids induce cytokine production in preadipocytes and sensitize cells to apoptotic assault. Obesity 2006;14(Suppl):A127.

22. Ziemke S, Bigornia S, Winter M, Apovian CM. Resting energy expenditure in morbidly obese subjects: a validation of the SenseWear armband. Obesity 2006;14(Suppl):A214.

23. Vitseva O, Tanriverdi K, Tchkonia T, Kirkland J, Apovian CM, Freedman J, Gokce N. Inducible Toll-like receptor and NF-kB regulatory pathway expression in human adipose tissue. Obesity 2007;15(Suppl):A28.

24. Abramof-Ness R, Chen E, Apovian CM, Kovatz S, Ganem G, Rotman-Pikielny P, Pomeranz M, Weiss E, Shapiro M, Shenkman L. Evaluation of the hypothalamic pituitary adrenal axis and metabolic profile of obese women with the polycystic ovary syndrome. Obesity 2007;15(Suppl):A104.

25. Zhongjing C, Hallock K, Bigornia S, Hua N, Guo Z, Phinikaridou A, Qiao Y, Viereck J, Apovian CM, Ruberg F, Hamilton J. Epicardial fat volume is associated with cardiac function independent of body mass index. Obesity 2007;15(Suppl):A190.

26. Apovian CM, Cullum-Dugan D, Murphy M, Meyers K, Coffman J, Jenkins M, Bakun P, Tucker KL. DASH for health: validation of web-based 24-hour recall questionnaire designed for a lifestyle modification program. Obesity 2007;15(Suppl):A192.

27. Bigornia S, Meyers M, Vita J, Apovian CM, Hess D, Gokce N. Long-term successful weight loss improves vascular endothelial function in extremely obese individuals. Obesity 2007;15(Suppl):A216.

28. Hamburg NM, Mott M, Bigornia S, Apovian CM, Hess D, Vita JA, Gokce N. Arterial remodeling in obesity is reversed with weight loss. Vascular Medicine, May 2008.

29. Mott M, Bigornia S, Tanriverdi K, Morin K, Apovian CM, McDonnell M, Vita J, Freedman J, Gokce N. Downregulation of adipose mitochondrial genes is associated with impaired glycemic control in obese subjects. Obesity 2008;16(Suppl):S184.

30. Bigornia S, Mott M, Tanriverdi K, Morin K, Apovian CM, McDonnell M, Hess D, Freedman J, Gokce N. Hyperinsulinemia is associated with proatherogenic adipose gene expression in obese subjects. Obesity 2008;16(Suppl):S260.

31. Bigornia S, Young L, Hiralall L, Gokce N, Burke P, Apovian CM.. Food insecurity in an urban population: nutritional characteristics of food pantry participants. Obesity 2008;16(Suppl):S138.

32. Ziemke F, Usdan L, Phanachet P, Winter M, Khaodhiar L, Apovian CM. Changes in androgen levels, inflammatory markers and sexual function in obese women enrolled in a medical weight loss program. Obesity 2008;16(Suppl):S238.

33. Rubin D, Liang Y, Bigornia S, Mott M, Gokce N, Nikolajczyk B, Apovian C, Ganley-Leal L, McDonnell M.  Human B cell Toll-like Receptor Expression in Insulin Resistance. American Diabetes Association 2009. Abstract #53-LB.

34. Choi EY, Bigornia SJ, Phanachet P, LaValley MP, Ziemke F, Istfan N, Apovian CM. Predictors of successful weight loss in an urban, medically supervised weight management center. Obesity 2009;17(2):S123.

35. Shah M, Ruth MR, Port AM, Bourland AC, Apovian CM. Comparison of Compliance to a Low-Carbohydrate High-Protein, or Low-Fat High Fiber Diet. Obesity 2010. Abstract #222-P.

36. Rubino D, Apovian CM, Still CD, Mignon L, Burns C, Harris-Collazo R, Dunayevich E, Kim DD. Naltrexone SR/Bupropion SR Combination (NB) Therapy Shifts Subjects From the Obese to the Non-Obese Body Mass Index (BMI) Classes From the COR-II Phase 3, Double-Blind, Placebo-Controlled, 56-Week Study. Obesity 2010. Abstract #499-P.

37. Pramyothin P, Biancuzzo RM, Lu A, Hess DT, Apovian CM, Holick MF. Vitamin D in adipose tissue is not mobilized despite loss of fat mass after Roux-en-Y Gastric Bypass. Obesity 2010;18(Suppl 2):S56. Abstract#43-OR.

38. Mott M, Bigornia SJ, Farb MG, Tanriverdi K, Freedman JE, Joseph L, Morin K, Apovian CM, Vita J, Gocke N. Increased waist circumference and triglycerides are linked to adipose tissue inflammation in normal weight individuals. Obesity 2010;18(Suppl 2):S174. Abstract#582-P.

39. Bigornia SJ, Farb MG, Mott MM, Joseph L, Hess DT, Apovian CM, Vita J, Gokce N. Association between insulin resistance and macrophage-mediated inflammation in subcutaneous and visceral fat depots in obese subjects. Obesity 2010;18(Suppl 2): S206. Abstract#731-P.

40. Miciek RL, Storer TW, Elmi A, Thompsen A, Nahigyan A, Bourland A, Apovian C. Progressive resistance exercise training in class III obese surgical candidates. Endocrine Society 2011 Abstract# P1-478.

41. Rubino D, Apovian C, Mignon L, Burns C, Harris-Collazo R, Kim D. Effects of naltrexone SR/bupropion SR on weight and obesity-related health risks in overweight/obese women from the COR-II trial. Diabetes 2011;60(Suppl 1):A504.

42. Mechanick JI, Marchetti A, Apovian C, Jenkins DJA, Leiter LA, Galvis AB. Task force for development of transcultural algorithms in nutrition and diabetes. A Transcultural Diabetes-Specific Nutrition Algorithm. Diabetes 2011;60(Suppl 1):A578.

43. Dao MC, Ruth MR, Karastergiou K, Apovian CM, Fried SK, Meydani SN. Impact of weight loss through calorie restriction on iron status, inflammation and hepcidin expression in circulation and adipose tissue of obese individuals. FASEB J 2012;26:lb320.

44. Bourland A, Ruth M, Pitkin A, Shah M, Lee-Parritz A, Apovian CM. Weight Loss Intervention in Underserved Postpartum Women. Boston University School of Medicine Evans Research Day 2013, # 2013-A-116-BUSM.

45. Wee CC, Mukamal K, Huskey K, Davis RB, Colten ME, Bolcic-Jankovic D, Apovian CM, Jones DB, Blackburn GL. High Risk Alcohol Use after Weight Loss Surgery: Is It All Bad? 30th Annual Meeting of the ASMBS at ObesityWeekSM 2013.

46. Bourland AC, Pitkin A, Mahesri M, Sullivan L, Apovian CM. Behavioral Intervention in Underserved Overweight Postpartum Women – Does it Work? Obesity WeekSM 2014. Abstract #T-2045-P.

47. Karastergiou K, Pramyothin P, Port A, Apovian CM, Lee M, Fried SK. Pulsatile Delivery of Cortisol Regulates Lipid Storage in Adipocytes In Vitro and Human Adipose Gene Expression In Vivo. Obesity WeekSM 2014. Abstract #T-2010-P.

48. Karastergiou K, Pramyothin P, Port A, Apovian CM, Lee M, Fried SK. Cortisol Interacts with Meal-Induced Signals to Acutely Regulate Adipose Tissue Gene Expression. Obesity WeekSM 2014. Abstract #T-2011-P.

49. Hamilton JA, Hua N, Apovian CM, Ruberg F. MRI Finds Dramatic Loss of Pericardial Fat after Gastric Bypass Surgery. Obesity WeekSM 2014. Abstract #T-2575-P.

50. Apovian CM, Fain R, Glicklich A, Ma T, Shanahan W. Impact of Sulfonylurea (SFU) Use on Weight Loss (WL) Achieved with Lorcaserin (LOR). American Diabetes Association 75th Scientific Sessions, June 2015. Abstract #5187.

51. Metformin counters a pro-inflammatory T cell profile in obesity. Obesity WeekSM 2015. Oral Presentation.

52. Sustained Improvements in Cardiovascular and Metabolic Risk Factors and Quality of Life at Two Years with Vagal Nerve Block in the ReCharge Trial. Obesity WeekSM 2015. Oral Presentation.

Financial Disclosures for Caroline Apovian MD, FACP, FACN

EndocrineWeb, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, or an immediate family member, have a financial interest(s) or affiliation(s) with the following commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Vertical Health, LLC’s websites.

Disclosed Relationships

Grants/Research Support
Has received research funding from Lilly, Amylin, Aspire Bariatrics, GI Dynamics, Pfizer, Sanofi-Aventis, Orexigen, MetaProteomies, and the Dr. Robert C. and Veronic Atkins Foundation, MYOS Corporation
Consultant
Has participated on the Advisory Boads for Amylin, Merck, Johnson and Johnson, Arena, Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, EnteroMedics, Scientific Intake and Novo Nordisk
Speakers' Bureau
Takeda Speakers Bureau for the medication Contrave
Other Financial or Material Support
Ownership interest in Science Smart LLC
SHOW MAIN MENU
SHOW SUB MENU